Millipore Corp

Millipore — Q1 2010 Earnings Presentation

7 slides from Millipore's earnings presentation, May 7, 2010

  1. Slide 1: Advancing Life Science Together: Millipore Q1 Earnings Conference Call

    ADVANCING LIFE SCIENCE TOGETHER® May 6, Millipore Q1 Earnings Conference Call Martin Madaus , Chairman & CEO Charles Wagner , Chief Financial Officer Joshua Young , Director of Investor Relations

  2. Slide 2: Forward-Looking Statements / Reg. G

    2 Forward-Looking Statements / Reg. G In order to take advantage of the safe harbor provisions of the private securities litigation reform act of 1995, you should understand that we will be making forward-looking statements in this conference. These statements involve a number of risks and uncertain

  3. Slide 3: Q1 2010: An Outstanding Quarter for Millipore

    1 2 3 4 Highest level of quarterly sales: $463M Solid improvement in non-GAAP EPS: $1.21 Substantial investment in R&D: 19% Working capital improvements drive $77M in free cash flow Q1 2010: An Outstanding Quarter for Millipore

  4. Slide 4: Q1 2010 Highlights

    4 *Excludes effects from changes in foreign currency Q1 2010 Highlights • Top-line revenues well-balanced – 9% organic* revenue growth in both Bioprocess and Bioscience divisions – New products driving – Americas & Asia grew double-digits • Bioscience Division rebounded – Lab instrument sales strong

  5. Slide 5: Q1 2010 GAAP Results

    5 REVENUES $463.0 $407.9 14% GROSS PROFIT % of revenues $259.4 56.0% $223.3 54.7% 16% SG&A % of revenues $141.1 30.5% $126.8 31.1% 11% R&D % of revenues $ 30.1 6.5% $ 25.2 6.2% 19% OPERATING PROFIT % of revenues $ 88.1 19.0% $ 71.3 17.5% 24% NET INCOME ATTRIBUTABLE TO MILLIPORE $ 57.2 $ 53.0 8% EPS

  6. Slide 6: Q1 2010 Non-GAAP Results

    6 REVENUES $463.0 $407.9 14% GROSS PROFIT* % of revenues $261.9 56.6% $229.5 56.3% 14% OPERATING PROFIT* % of revenues $104.5 22.6% $ 90.7 22.2% 15% NET INCOME ATTRIBUTABLE TO MILLIPORE* $ 70.2 $ 59.2 19% EPS* $ 1.21 $ 1.06 14% Q1 Q1 % (Dollars in millions, except per share data) * Non-GAAP, please

  7. Slide 7: Balance Sheet

    7 CASH $223 $168 $172 ACCOUNTS RECEIVABLE DSO $315 63 Days $281 59 Days $289 67 Days INVENTORY Days of Inventory $238 109 Days $258 118 Days $253 129 Days DEBT $885 $933 $1,073 (Dollars in millions) Apr. 3, Dec. 31, 2009 Apr. 4, Balance Sheet

Millipore — Q1 2010 Earnings Presentation on 6ix